SNOA | Sonoma Pharmaceuticals, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)

*Sign In to persist settings

Financial Year End	2024-03-31	2023-03-31	2022-03-31	2021-03-31	2020-03-31	2019-03-31	2018-03-31	2017-03-31	2016-03-31	2015-03-31	2014-03-31	2013-03-31	2012-03-31	2011-03-31	2010-03-31	2009-03-31	2008-03-31	2007-03-31	2006-03-31	2005-03-31	2004-03-31	2003-03-31	2002-03-31
Revenue	12.73M	13.27M	12.63M	18.63M	18.94M	18.97M	16.66M	12.82M	15.08M	13.85M	13.67M	15.45M	12.74M	9.75M	7.36M	5.39M	3.83M	4.54M	2.58M	1.36M	902.00K	2.47M	2.00M
Cost of Revenue	7.99M	8.79M	8.63M	12.07M	10.60M	10.09M	9.35M	7.16M	7.87M	6.57M	5.27M	4.71M	4.03M	3.61M	3.49M	2.59M	2.75M	3.00M	4.90M	3.52M	N/A	1.77M	815.00K
Gross Profit	4.75M	4.48M	3.99M	6.56M	8.33M	8.88M	7.31M	5.67M	7.21M	7.29M	8.40M	10.74M	8.71M	6.14M	3.88M	2.80M	1.08M	1.54M	-2.32M	-2.17M	902.00K	702.00K	1.19M
Operating Expenses	9.45M	9.05M	9.88M	10.01M	15.00M	20.14M	21.50M	18.64M	17.36M	13.95M	14.45M	14.12M	15.18M	13.65M	11.89M	20.11M	23.51M	21.03M	18.53M	14.15M	N/A	2.17M	1.33M
Selling, General & Admin	7.58M	8.84M	9.76M	9.45M	13.66M	18.62M	19.92M	17.07M	15.56M	12.41M	11.56M	11.89M	13.20M	11.60M	9.90M	13.86M	13.73M	16.52M	15.93M	12.49M	N/A	2.10M	1.33M
Research & Development	1.87M	207.00K	125.00K	555.00K	1.34M	1.52M	1.57M	1.58M	1.81M	1.53M	2.89M	2.22M	1.98M	2.05M	2.00M	6.25M	9.78M	4.51M	2.60M	1.65M	N/A	68.00K	6.00K
Other Operating Expenses	N/A	-631.00K	-394.00K	-594.00K	240.00K	-239.00K	-357.00K	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Income	-4.70M	-4.57M	-5.89M	-3.45M	-6.67M	-11.26M	-14.19M	-12.97M	-10.15M	-6.66M	-6.05M	-3.37M	-6.47M	-7.50M	-8.02M	-17.31M	-22.43M	-19.48M	-20.85M	-16.31M	902.00K	-1.47M	-147.00K
Other Expenses / Income	-330.00K	-614.00K	469.00K	-453.00K	3.85M	-82.00K	-139.00K	37.00K	-10.00K	-1.54M	9.79M	-2.06M	-862.00K	-443.00K	-216.00K	-349.00K	2.09M	-299.00K	-267.00K	-218.00K	-902.00K	-4.00K	4.00K
Before Tax Income	-5.03M	-5.18M	-5.42M	-3.90M	-2.83M	-11.34M	-14.33M	-12.94M	-10.16M	-8.20M	3.73M	-5.43M	-7.33M	-7.95M	-8.23M	-17.66M	-20.34M	-19.78M	-21.23M	-16.17M	N/A	-1.47M	-143.00K
Income Tax Expenses	-196.00K	-33.00K	-332.00K	713.00K	121.00K	458.00K	-807.00K	-4.27M	-241.00K	-250.00K	774.00K	839.00K	862.00K	443.00K	-217.00K	349.00K	-2.09M	299.00K	2.25M	218.00K	8.04M	123.00K	24.00K
Net Income	-4.83M	-5.15M	-5.09M	-4.62M	-2.95M	-11.80M	-14.33M	9.27M	-10.16M	-8.20M	3.73M	-5.43M	-7.33M	-7.95M	-8.23M	-17.66M	-20.34M	-19.78M	-23.10M	-16.53M	-7.30M	-1.59M	-167.00K
Interest Expenses	N/A	16.00K	10.00K	12.00K	16.00K	33.00K	40.00K	3.00K	3.00K	3.00K	1.06M	1.11M	931.00K	406.00K	9.00K	437.00K	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Basic Shares Outstanding	454.50K	169.70K	132.65K	99.80K	73.85K	46.20K	25.15K	23.47K	18.27K	10.73K	7.65K	5.53K	4.35K	4.19K	3.65K	2.57K	2.02K	864.00	658.00	621.00	620.00	607.00	602.00
Diluted Shares Outstanding	454.50K	169.70K	132.65K	99.80K	73.85K	46.20K	25.17K	23.72K	18.27K	10.73K	7.66K	5.53K	4.35K	4.19K	3.65K	2.57K	2.02K	864.00	658.00	621.00	620.00	607.00	602.00
EBITDA	-4.53M	-4.45M	-5.70M	-3.22M	-3.22M	-10.85M	-13.80M	-12.69M	-14.48M	-7.95M	-5.77M	-4.06M	-6.07M	-7.15M	-7.79M	-16.45M	-22.43M	-18.81M	-20.20M	-15.88M	902.00K	-1.46M	-151.00K
EBITDA Margin	-35.53%	-33.49%	-45.15%	-17.30%	-16.98%	-57.22%	-82.83%	-98.92%	-95.98%	-57.36%	-42.19%	-26.25%	-47.65%	-73.27%	-105.78%	-305.33%	-584.75%	-414.09%	-781.73%	-1,170.94%	100.00%	-59.27%	-7.55%
EBIT	-5.03M	-5.17M	-5.41M	-3.89M	-2.81M	-11.31M	-15.10M	5.01M	-10.40M	-8.45M	5.57M	-3.48M	-5.54M	-7.10M	-8.44M	-16.87M	-22.43M	-19.48M	-20.85M	-16.31M	742.00K	-1.47M	-143.00K
EBIT Margin	-39.51%	-38.94%	-42.83%	-20.88%	-14.83%	-59.60%	-90.62%	39.06%	-68.95%	-60.99%	40.73%	-22.55%	-43.44%	-72.78%	-114.61%	-313.10%	-584.75%	-428.88%	-806.93%	-1,202.95%	82.26%	-59.60%	-7.15%
Financial Year End	2024-03-31	2023-03-31	2022-03-31	2021-03-31	2020-03-31	2019-03-31	2018-03-31	2017-03-31	2016-03-31	2015-03-31	2014-03-31	2013-03-31	2012-03-31	2011-03-31	2010-03-31	2009-03-31	2008-03-31	2007-03-31	2006-03-31	2005-03-31	2004-03-31	2003-03-31	2002-03-31